Analytical confidence from sequence to biological activity 

Peptide and oligonucleotide quality depends on sequence, purity and content, and on resolving closely related impurities that elute right next to the main product. Whether you work with drug substance or drug product, we design phase-appropriate analytical strategies that cover identity, purity, content, stability and potency. Orthogonal chromatography and high-resolution MS in one lab, from early development to GMP release.

In this application note we provide an analytical package for synthetic peptide and oligonucleotide drug substances and products.